Visser Loes E, Penning-van Beest Fernie J A, Wilson J H P, Vulto Arnold G, Kasbergen A A Harrie, De Smet Peter A G M, Hofman Albert, Stricker Bruno H Ch
Pharmaco-epidemiology Unit, Departments of Internal Medicine and Epidemiology & Biostatistics, Erasmus MC, Rotterdam, The Netherlands.
Br J Clin Pharmacol. 2004 Apr;57(4):522-4. doi: 10.1046/j.1365-2125.2003.02036.x.
Some medical textbooks on drug interactions take note of the potential interaction between laxatives and coumarin anticoagulants, but epidemiological evidence that this interaction is of practical importance is lacking. We conducted a follow-up study in a large population-based cohort to investigate which laxatives are associated with overanticoagulation during therapy with coumarins. Of the 1124 patients in the cohort, 351 developed an International Normalized Ratio > or = 6.0. The only laxative with a moderate but significantly increased relative risk of overanticoagulation was lactulose (relative risk 3.4, 95% confidence interval 2.2, 5.3). In view of the widespread use of lactulose, especially among the elderly, awareness of this potential drug interaction is required.
一些关于药物相互作用的医学教科书提到了泻药与香豆素抗凝剂之间的潜在相互作用,但缺乏表明这种相互作用具有实际重要性的流行病学证据。我们在一个基于人群的大型队列中进行了一项随访研究,以调查哪些泻药与香豆素治疗期间的抗凝过度有关。该队列中的1124名患者中,有351名患者的国际标准化比值≥6.0。唯一一种与抗凝过度的相对风险有中度但显著增加相关的泻药是乳果糖(相对风险3.4,95%置信区间2.2,5.3)。鉴于乳果糖的广泛使用,尤其是在老年人中,需要了解这种潜在的药物相互作用。